Yellow fever vaccin
Ended Awarded Last action
- Contract number
- SPE2DP26F0687
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $3,340
Award facts
- Contract value 100% obligated
- $3,340.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $3,340.26 to DMS Pharmaceutical Group Inc. for yellow fever vaccine on November 13, 2025. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency, which was established under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, and operates as a critical supplier within the federal pharmaceutical supply chain. The contract contains no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement.
The underlying PPV-G GEN V contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. This delivery order for yellow fever vaccine supports the Department of Defense's recurring medical supply requirements and represents one of numerous delivery orders DMS Pharmaceutical Group has received from the Defense Logistics Agency since October 2025. The company's product portfolio encompasses an extensive range of pharmaceuticals including vaccines, branded and generic prescription medications, biologics, specialty pharmaceuticals, and medical consumables that serve military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DP26F0687?
SPE2DP26F0687 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 13, 2025.
How much is contract SPE2DP26F0687 worth?
The government has obligated $3,340 on SPE2DP26F0687.
Is contract SPE2DP26F0687 an order under another contract?
Yes. SPE2DP26F0687 is a delivery order under SPE2DX25D9900, an indefinite delivery contract.
Was contract SPE2DP26F0687 competed?
The extent of competition for SPE2DP26F0687 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award